DK0899330T3 - Polypeptid isoleret fra epidermis og dets anvendelser - Google Patents

Polypeptid isoleret fra epidermis og dets anvendelser

Info

Publication number
DK0899330T3
DK0899330T3 DK98402037T DK98402037T DK0899330T3 DK 0899330 T3 DK0899330 T3 DK 0899330T3 DK 98402037 T DK98402037 T DK 98402037T DK 98402037 T DK98402037 T DK 98402037T DK 0899330 T3 DK0899330 T3 DK 0899330T3
Authority
DK
Denmark
Prior art keywords
epidermis
applications
polypeptide isolated
polypeptide
intercorneocytary
Prior art date
Application number
DK98402037T
Other languages
English (en)
Inventor
Dominique Bernard
Michel Kermici
Marie-Alix Bernard-Bourboulon
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of DK0899330T3 publication Critical patent/DK0899330T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98402037T 1997-08-29 1998-08-11 Polypeptid isoleret fra epidermis og dets anvendelser DK0899330T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710818A FR2767833B1 (fr) 1997-08-29 1997-08-29 Polypeptide isole de l'epiderme et son utilisation

Publications (1)

Publication Number Publication Date
DK0899330T3 true DK0899330T3 (da) 2004-06-28

Family

ID=9510611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98402037T DK0899330T3 (da) 1997-08-29 1998-08-11 Polypeptid isoleret fra epidermis og dets anvendelser

Country Status (9)

Country Link
US (2) US6274364B1 (da)
EP (1) EP0899330B1 (da)
JP (1) JP3819603B2 (da)
AT (1) ATE267249T1 (da)
CA (1) CA2243633C (da)
DE (1) DE69823935T2 (da)
DK (1) DK0899330T3 (da)
ES (1) ES2221133T3 (da)
FR (1) FR2767833B1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767833B1 (fr) * 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation
US6852686B2 (en) * 1999-06-23 2005-02-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for ameliorating icthyosiform skin diseases
DE19945486A1 (de) * 1999-09-22 2001-03-29 Henkel Kgaa Verfahren zur Färbung von keratinischen Fasern
DE19945487A1 (de) * 1999-09-22 2001-03-29 Henkel Kgaa Verfahren zur Restrukturierung keratinischer Fasern
DE10050274A1 (de) * 2000-10-09 2002-04-18 Henkel Kgaa Verfahren zur in vitro Bestimmung der Hautalterung
FR2816838B1 (fr) * 2000-11-17 2004-12-03 Oreal Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
FR2842209B1 (fr) 2002-07-09 2007-11-23 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
FR2846148A1 (fr) 2002-10-17 2004-04-23 Thomson Licensing Sa Encapsulation des panneaux oled a emission vers le haut
FR2888494B1 (fr) * 2005-07-13 2014-03-14 Oreal Utilisation de composes d'uree pour favoriser la desquamation
WO2007024915A1 (en) * 2005-08-26 2007-03-01 Elc Management Llc Cosmetic composition containing a protease activator
US20080050331A1 (en) * 2006-08-23 2008-02-28 Paolo Giacomoni Cosmetic Composition Containing A Protease Activator
FR2914189A1 (fr) 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.
FR2918269B1 (fr) 2007-07-06 2016-11-25 Oreal Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses.
FR2918561B1 (fr) 2007-07-09 2009-10-09 Oreal Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage.
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
FR2939036B1 (fr) 2008-12-01 2010-12-17 Oreal Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition
CN102378621A (zh) 2009-04-02 2012-03-14 高露洁-棕榄公司 剥离性洁牙剂组合物及其使用方法
FR2946845B1 (fr) 2009-06-18 2011-08-19 Oreal Dispositif de traitement des matieres keratiniques humaines
FR2954140A1 (fr) 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
CN102933194A (zh) 2009-12-18 2013-02-13 欧莱雅公司 涉及能够原位缩合的化合物的美容处理方法
FR2956582B1 (fr) 2010-02-19 2012-08-24 Oreal Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
FR2968569B1 (fr) 2010-12-13 2013-01-04 Oreal Procede de traitement de la peau grasse non acneique.
FR3133014A1 (fr) 2022-02-28 2023-09-01 L'oreal Compositions et procédés pour améliorer l’aspect de la peau
FR3134006A1 (fr) 2022-04-01 2023-10-06 L'oreal compositions et procédés pour améliorer l’aspect de la peau
WO2024049923A1 (en) 2022-08-31 2024-03-07 L'oreal Compositions and methods for skin
FR3143355A1 (fr) 2022-12-14 2024-06-21 L'oreal Compositions et procédés de prévention et/ou de traitement des cicatrices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710014A (en) * 1988-02-11 1998-01-20 The United States Of America As Represented By The Department Of Health And Human Services Cloned cDNA for human procathepsin l.
JPH06192124A (ja) * 1992-12-25 1994-07-12 Toray Ind Inc 血液細胞増加剤
GB9319104D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
GB2306961B (en) * 1995-11-04 1998-06-10 Zeneca Ltd Cathepsin L at high specific actvity and recombinant manufacture thereof
DE19619366A1 (de) * 1996-05-14 1997-11-20 Hoechst Ag Cathepsin-L, dessen Präpoform und das entsprechende Propeptid aus Ciliaten
FR2767833B1 (fr) * 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation

Also Published As

Publication number Publication date
US20020006654A1 (en) 2002-01-17
DE69823935T2 (de) 2005-05-25
FR2767833A1 (fr) 1999-03-05
DE69823935D1 (de) 2004-06-24
EP0899330A1 (fr) 1999-03-03
CA2243633C (fr) 2008-06-03
EP0899330B1 (fr) 2004-05-19
JP3819603B2 (ja) 2006-09-13
FR2767833B1 (fr) 2001-03-02
US6274364B1 (en) 2001-08-14
ATE267249T1 (de) 2004-06-15
US6737055B2 (en) 2004-05-18
CA2243633A1 (fr) 1999-02-28
JPH11139933A (ja) 1999-05-25
ES2221133T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
DK0899330T3 (da) Polypeptid isoleret fra epidermis og dets anvendelser
EA200000933A1 (ru) Пептидные композиции и препараты и их применение
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
ATE356607T1 (de) Verwendung von nativem zein zur verbesserung des haarzustandes und mittel
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
WO1996017924A3 (en) Novel hedgehog-derived polypeptides
MY140581A (en) Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
BR0115665A (pt) Composição de tratamento das queratìnicas, uso de uma composição, processo de tratamento das matérias queratìnicas e uso de pelo menos um poliuretano associativo catiÈnico
DE69108256D1 (de) Anwendug der saponine von medicago für die herstellung von kosmetischen oder pharmazeutischen namentlich dermatologischen zusammensetzungen welche die erneuerung der epidermis fördern,das wiederwachstum der haare stimulieren oder ihren ausfall verzögern.
ATE296124T1 (de) Haut/haar-äquivalent mit rekonstruierten papillen
FR2822375B1 (fr) Composition contenant des fibres, et ses utilisations notamment cosmetiques
PT751778E (pt) Utilizacao de agua com teor reduzido de deuterio para a producao de preparacoes higienicas e cosmeticas
ATE459644T1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
TW200518781A (en) Compositions for achieving benefits in skin using key cellular metabolic intermediates
ATE387179T1 (de) Haltbare kosmetische zusammensetzung, die ein bestimmtes haftungsförderndes material enthält
DE60229235D1 (de) D kupfersulfaten und sucralphat
HUP0000642A2 (hu) Izzadásgátló vagy dezodoráló készítmény, valamint eljárás előállítására
ES2184971T3 (es) Utilizacion de polidimetilsiloxanos de grupos glucosidos como agentes hidratantes en una composicion cosmetica o dermatologica.
DE69805435D1 (de) Verwendung eines diphenyldimethicongummis gelösst in einem nichtflüchtigen silikon des phenyltrimethicontyps zur herstellung von einem kosmetischen oder pharmazeutischen , insbesondere dermatologischen zusammensetzung die eine fettphase enthält
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
TW200708312A (en) Cosmetic composition used for cleaning skin
WO2001051511A3 (de) Rekombinante herstellung von humanen histon 1-subtypen sowie deren verwendung für therapeutische zwecke
FR2831447B1 (fr) Absolues de bulbes d'allium sativum et utilisations a titre therapeutique ou cosmetique